Liv Hospital health content is written by a content specialist, verified by an independent expert and medically approved by a physician in the relevant field.
- Uğurkan DemirWriter
- Lamiya GurbanovaFact-checker
- Spec. MD. Ömer GezdurMedical reviewer
Uğurkan Demir is a Medical Content Writer with experience creating clear, well-researched,…
View author profile →
Dr. Lamiya Gurbanova is a physician who completed her specialization training in…
View profile →
Approved this content for clinical accuracy in their specialty.
View doctor profile →We review our content at regular intervals and update it whenever new research or a change in clinical guidelines requires it.
Overview
What Is Mycosis Fungoides?
Mycosis fungoides is a rare cancer of T lymphocytes, a type of white blood cell that helps the immune system. It commonly begins in the skin and is a form of cutaneous T-cell lymphoma. The disease often progresses slowly, but it can behave differently from person to person. Although sometimes called lymphoma fungoides or fungoides cancer, it is not the same as a skin infection.
Symptoms
Symptoms of Mycosis Fungoides
- Persistent flat patches of skin that do not clear as expected
- Raised or thicker skin lesions called plaques
- Darker, lighter, red, or otherwise changed skin color
- Itching, which may range from mild to severe
- Thinning or atrophy of the affected skin
- Firm or raised tumors on the skin
- Enlarged lymph nodes (swollen glands)
- More advanced symptoms such as fever, night sweats, unexplained weight loss, or marked fatigue
Causes
What Causes Mycosis Fungoides?
Mycosis fungoides begins when T lymphocytes acquire changes that allow abnormal cells to persist and collect in the skin. These cells can produce patches, plaques, or tumors as the disease develops. The exact initiating cause is usually unknown, and researchers do not identify one specific exposure or behavior that causes this mycosis.
Risk Factors
Risk Factors for Mycosis Fungoides
- Older age, because diagnosis is more common in later adulthood
- Male sex, which is associated with a higher occurrence in some population studies
- Certain population patterns involving ancestry or geographic background; these associations are limited and do not predict an individual’s risk
- A family history of lymphoma may be considered during evaluation, although mycosis fungoides is not usually inherited
- An unexplained or unknown cause, since many people have no identifiable risk factor
No proven lifestyle change reliably prevents mycosis fungoides. Having a possible risk factor does not mean someone will develop it, and people without recognized risk factors can still be diagnosed.
Side Effects & Complications
Complications and Treatment Side Effects
| Area | Possible problems | What to discuss with the care team |
|---|---|---|
| Skin disease | Pain, cracking, infection, or extensive skin involvement | New or worsening lesions, drainage, fever, or uncontrolled discomfort |
| Lymph nodes or organs | Progression beyond the skin in advanced disease | New swelling, unexplained weight loss, fevers, or night sweats |
| Skin-directed treatment | Irritation, dryness, redness, or pigment changes | Persistent or severe reactions |
| Systemic treatment | Medicine-specific effects such as fatigue, infection risk, or blood-count changes | Any new symptom and recommended monitoring results |
Seek prompt medical advice
Report concerning changes
Contact your oncology or dermatology team promptly for rapidly worsening skin disease, signs of infection, severe treatment reactions, breathing problems, or significant new symptoms such as persistent fever, night sweats, or unexplained weight loss.
Diagnosis & Staging
Diagnosis and Staging
Diagnosis starts with a clinical skin examination and usually requires one or more skin biopsies. Blood tests can look for abnormal T cells and other changes, while lymph-node assessment may be needed if nodes are enlarged. Imaging or other tests may be recommended when spread beyond the skin is suspected. Because early disease can resemble other rashes, an experienced dermatopathologist or cutaneous-lymphoma team may review the biopsy.
| Staging feature | What it evaluates | Why it matters |
|---|---|---|
| T | Extent and type of skin involvement | Shows how much skin is affected and whether lesions are patches, plaques, or tumors |
| N | Lymph nodes | Shows whether nearby nodes are enlarged or contain lymphoma cells |
| M | Internal organs | Identifies spread beyond the skin and lymph nodes |
| B | Blood | Shows whether abnormal T cells are present in the bloodstream |
Stage helps guide treatment and provides information about outlook. Early skin-limited disease is managed differently from disease involving lymph nodes, the blood, or internal organs. Your care team combines examination, biopsy, laboratory, and imaging findings to determine the most appropriate plan.
Treatment Options
Treatment Options
Skin-directed treatments
Skin-directed therapy may be used when disease is limited to selected skin areas. Options can include topical medicines, phototherapy, and localized radiation. Treatment choice depends on the type of lesions, the body area involved, the extent of disease, symptoms, and response to previous treatment.
Systemic and advanced-disease treatments
More extensive or resistant disease may require targeted or immune-based medicines, other systemic therapies, radiation in selected situations, or a clinical trial. Stem cell transplantation is considered only for carefully selected patients. Treatment for mycosis fungoides is individualized, may combine several approaches, and often aims to control disease and symptoms over time rather than follow one one-time treatment plan.
Outlook and Prognosis
Outlook and Prognosis
Many cases of mycosis fungoides remain limited to the skin and can be managed for years. Some cases become more extensive or aggressive, including spread to lymph nodes, blood, or internal organs. Because the course varies widely, an individual survival estimate should be discussed with the treating specialist rather than inferred from general information.
- Stage at diagnosis
- Amount and type of skin involvement
- Whether lymph nodes or internal organs are involved
- Whether abnormal cells are present in the blood
- Age and overall health
- Response to treatment and how long control lasts
Survivorship & Follow-up
Survivorship and Follow-Up
- Attend scheduled skin and lymph-node examinations
- Complete blood tests or imaging when your care team recommends them
- Track new, spreading, thickening, or changing lesions with notes or photographs
- Review treatment effects, skin care needs, and symptom control at visits
- Keep a current list of medicines, treatments, allergies, and specialist contacts
- Maintain an up-to-date care plan that identifies who to contact with concerns
Follow-up frequency is individualized according to stage, treatment, response, and symptoms. Report new lesions, persistent itching, swollen lymph nodes, fevers, night sweats, or unexplained weight loss promptly rather than waiting for the next appointment.
Branches
2 topics
Mycosis Fungoides
Dermatology
Mycosis Fungoides
Hematology
Tests & Procedure
2 topics
Mycosis Fungoides
Bone Marrow Transplant
Mycosis Fungoides
Lymphocytes Blood Test
Symptoms
1 topic
Mycosis Fungoides
Night Sweats
